Abstract
Physical activity has a substantial impact on health and mortality. Besides questionnaires that rely on subjective assessment of activity levels, accelerometers can help to objectify an individual’s physical activity.
Physical activity was assessed with the GT3X activity monitor (ActiGraph LLC, USA) in 797 participants of the Berlin Aging Study II (BASE-II) and compared with questionnaire data obtained from the Rapid Assessment of Physical Activity (RAPA).
Of all participants, 760 fulfilled the wear-time based inclusion criteria. Mean age was 75.6 years (SD: 3.8 years, range 66.0 – 94.1 years) and 53% of the included participants were female. Average wear time was 23.2 hours/day (SD 1.3 hours/day). Statistically significant differences between RAPA groups were found for all accelerometric variables except energy expenditure. Post-hoc analysis, however, suggested low agreement between subjective and objective assessment of physical activity. When focusing on the first question of the RAPA questionnaire, participants who reported to be “seldom or never active” showed statistically significant lower activity levels in Vector Magnitude, step counts, and cut-off defined moderate physical activity (p<0.05). Total cholesterol, high density lipoprotein cholesterol, low density lipoprotein cholesterol, triglycerides, fasting glucose and hemoglobin A1c were weakly correlated with accelerometric variables (Pearson’s r ≤ 0.25).
Results from this study suggest that subjectively assessed data from the RAPA and objectively assessed data from accelerometric variables obtained from the GT3X monitor are partially inconsistent in terms of the physical activity level of the participants.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This article uses data from the Berlin Aging Study II (BASE-II) and the GendAge study which were supported by the German Federal Ministry of Education and Research under grant numbers #01UW0808; #16SV5536K, #16SV5537, #16SV5538, #16SV5837, #01GL1716A and #01GL1716B.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee of Charité - Universitätsmedizin Berlin, Germany, gave ethical approval for this work (approval number EA2/144/16).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Due to concerns for participant privacy, data are available only upon reasonable request. Please contact Ludmila Mueller, scientific coordinator, at lmueller{at}mpib-berlin.mpg.de, for additional information.
